Nanomedicine for Cancer Diagnosis and Therapy

Nanomaterials have emerged as a promising tool for cancer diagnostics and therapy, with applications in drug delivery systems, immune cell activation, tumor microenvironment modulation, and detection, prevention, and treatment of solid tumors and leukemia/lymphomas. However, ethical issues in nanomedicine must be addressed, including risk assessment, risk management, and risk communication during clinical trials. This book provides a valuable source of information for students, academics, researchers, scientists, clinicians, and healthcare professionals working in nanotechnology and cancer research.

Format: Hardback
Length: 249 pages
Publication date: 01 July 2021
Publisher: Springer Verlag, Singapore

Nanomaterials have gained significant attention in recent years for their potential applications in cancer diagnostics and therapy. This book provides a comprehensive review of the current applications and future prospects of nanomaterials in this field. Nanomaterials possess unique intrinsic molecular properties that make them promising tools for cancer therapy and diagnosis. However, there are several limitations associated with the use of nanoparticles in drug delivery systems. To overcome these limitations, attempts have been made to synthesize nanoparticles from biological materials, which can mimic natural components of the body and offer effective and versatile drug delivery systems for cancer therapy. This book evaluates various potential bio-inspired platforms that mimic natural components of the body and offer effective and versatile drug delivery systems for cancer therapy. It also assesses the potential of nanoparticles to enhance the outcomes of cancer immunotherapy via immune cell activation and tumor microenvironment modulation. The book also summarizes the applications of nanomaterials for the detection, prevention, and treatment of solid tumors and in the treatment of leukemia and lymphomas. In closing, it discusses ethical issues in nanomedicine, including risk assessment, risk management, and risk communication during clinical trials. The book offers a valuable source of information for students, academics, researchers, scientists, clinicians, and healthcare professionals working in nanotechnology and cancer research.

Weight: 559g
Dimension: 235 x 155 (mm)
ISBN-13: 9789811575631
Edition number: 1st ed. 2021